Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
Lists
Only you see this
Abstract
Although proliferation is the strongest parameter predicting clinical outcome in the ER+/HER2- subtype and the common denominator of most prognostic gene signatures, immune response and tumor invasion seem to be the main molecular processes associated with prognosis in the ER-/HER2- and HER2+ subgroups, respectively. These findings may help to define new clinicogenomic models and to identify new therapeutic strategies in the specific molecular subgroups.
BibTeX
@inproceedings{desmedt2008biological,
author = {Christine Desmedt and Benjamin Haibe‐Kains and Pratyaksha Wirapati and Marc Buyse and Denis Larsimont and Gianluca Bontempi and Mauro Delorenzi and Martine Piccart and Christos Sotiriou},
title = {{Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes}},
booktitle = {Clinical},
year = {2008},
doi = {10.1158/1078-0432.ccr-07-4756},
}Loading related content...